StonvexLoading…
StonvexStonvexStonvexCore line items from DY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-25 | Q3 2025 2025-07-26 | Q2 2025 2025-04-26 |
|---|---|---|---|---|
Revenue | $5.55B | $4.09B | $2.64B | $1.26B |
Operating Income | $367.88M | $349.98M | $209.72M | $78.60M |
Net Income | $281.19M | $264.90M | $158.53M | $61.05M |
EPS (Diluted) | $9.56 | $9.05 | $5.42 | $2.09 |
Total Assets | $5.98B | $3.32B | $3.22B | $3.10B |
Total Liabilities | $4.12B | $1.84B | $1.85B | $1.84B |
Cash & Equivalents | $709.16M | $110.11M | $28.46M | $16.12M |
Free Cash Flow OCF − CapEx | $401.71M | $37.10M | $-127.71M | $-133.47M |
Shares Outstanding | 29.97M | 28.96M | 28.95M | 28.92M |